Literature DB >> 2338899

MRI characterization of 9L-glioma in rat brain at 4.7 Tesla.

S S Rajan1, L Rosa, J Francisco, A Muraki, M Carvlin, E Tuturea.   

Abstract

In vivo estimation of intracranial tumor progression is important in tumor treatment response studies in animal models. High resolution MR images at 4.7 T of 9L-gliomas stereotactically implanted in Fisher-344 rat brains were obtained. Due to elongation of T1 at higher fields, tissue contrast is diminished in T1-weighted images. However, normal anatomy and vasogenic edema are clearly discerned in T2-weighted images (echo times of greater than 50 ms and recycle times of greater than 2 sec). Tumor tissue is not always clearly delineated. Images obtained after administration of contrast agents (Gadolinium DTPA), with short TR (0.6 sec) selectively enhanced the tumorous tissue, with little effect upon normal tissue and edema. Good correlation of enhanced tumor lesions has been observed with histological examination of formalin fixed brains. Relaxation times (T1 and T2) of tumor and normal tissues were measured using stimulated-echo and multi-echo sequences, respectively. Serial images corresponding to tumor growth were recorded, from which tumor volume progression was monitored.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2338899     DOI: 10.1016/0730-725x(90)90252-w

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  11 in total

1.  Quantitative magnetization transfer imaging of rodent glioma using selective inversion recovery.

Authors:  Junzhong Xu; Ke Li; Zhongliang Zu; Xia Li; Daniel F Gochberg; John C Gore
Journal:  NMR Biomed       Date:  2013-12-13       Impact factor: 4.044

2.  Sequential imaging and volumetric analysis of an intracerebral C6 glioma by means of a clinical MRI system.

Authors:  F A Raila; A P Bowles; E Perkins; A Terrell
Journal:  J Neurooncol       Date:  1999-05       Impact factor: 4.130

3.  Characterization and detection of experimental rat gliomas using magnetic resonance imaging.

Authors:  A Vonarbourg; A Sapin; L Lemaire; F Franconi; P Menei; P Jallet; J J Le Jeune
Journal:  MAGMA       Date:  2004-10-20       Impact factor: 2.310

Review 4.  Rat brain tumor models in experimental neuro-oncology: the 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas.

Authors:  R F Barth
Journal:  J Neurooncol       Date:  1998-01       Impact factor: 4.130

5.  Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats. Involvement of the glucocorticoid receptor and vascular permeability factor.

Authors:  J D Heiss; E Papavassiliou; M J Merrill; L Nieman; J J Knightly; S Walbridge; N A Edwards; E H Oldfield
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

6.  Differential permeability and quantitative MR imaging of a human lung carcinoma brain xenograft in the nude rat.

Authors:  P A Barnett; S Roman-Goldstein; F Ramsey; C I McCormick; G Sexton; J Szumowski; E A Neuwelt
Journal:  Am J Pathol       Date:  1995-02       Impact factor: 4.307

7.  Characterization of brain tumours with spin-spin relaxation: pilot case study reveals unique T 2 distribution profiles of glioblastoma, oligodendroglioma and meningioma.

Authors:  Cornelia Laule; Thorarin A Bjarnason; Irene M Vavasour; Anthony L Traboulsee; G R Wayne Moore; David K B Li; Alex L MacKay
Journal:  J Neurol       Date:  2017-09-11       Impact factor: 4.849

8.  On the origins of chemical exchange saturation transfer (CEST) contrast in tumors at 9.4 T.

Authors:  Junzhong Xu; Moritz Zaiss; Zhongliang Zu; Hua Li; Jingping Xie; Daniel F Gochberg; Peter Bachert; John C Gore
Journal:  NMR Biomed       Date:  2014-01-29       Impact factor: 4.044

9.  NMR investigation of experimental chemical induced brain tumors in rats, potential of a superparamagnetic contrast agent (MD3) to improve diagnosis.

Authors:  V Rousseau; D Pouliquen; F Darcel; P Jallet; J J Le Jeune
Journal:  MAGMA       Date:  1998-08       Impact factor: 2.533

10.  In vivo detection of c-Met expression in a rat C6 glioma model.

Authors:  R A Towner; N Smith; S Doblas; Y Tesiram; P Garteiser; D Saunders; R Cranford; R Silasi-Mansat; O Herlea; L Ivanciu; D Wu; F Lupu
Journal:  J Cell Mol Med       Date:  2007-01-09       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.